Metraipolis › archive › dc_89fa9cfc7aa7

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers — Europe PMC PMID:41429932

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41429932
DOI
10.1038/s43018-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T11:21:35.990Z
SHA-256 of the archived text
07febf4917d7fe72621fc750f7a89db8c350cff07c3a22220c7a47ac12ce41a3
Stable URL of this page
https://metraipolis.com/documento/dc_89fa9cfc7aa7

How to cite

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers — Europe PMC PMID:41429932 — Europe PMC (en), https://europepmc.org/article/MED/41429932 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89fa9cfc7aa7 (Metraipolis archive dc_89fa9cfc7aa7, sha256 07febf4917d7fe72621fc750f7a89db8c350cff07c3a22220c7a47ac12ce41a3)
BibTeX
@misc{dc89fa9cfc7aa7,
  title = {TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers — Europe PMC PMID:41429932},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41429932},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89fa9cfc7aa7; sha256 07febf4917d7fe72621fc750f7a89db8c350cff07c3a22220c7a47ac12ce41a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41429932. Agents can read the archived copy with the MCP tool read_document.